S R Weinberger

Summary

Affiliation: Ciphergen Biosystems
Country: USA

Publications

  1. ncbi Recent trends in protein biochip technology
    S R Weinberger
    Ciphergen Biosystems, Inc, 6611 Dumbarton Circle, Fremont, CA 94555, USA
    Pharmacogenomics 1:395-416. 2000
  2. ncbi Current achievements using ProteinChip Array technology
    Scot R Weinberger
    Ciphergen Biosystems, 6611 Dumbarton Circle, Fremont, California 94555, USA
    Curr Opin Chem Biol 6:86-91. 2002
  3. ncbi Surface-enhanced laser desorption-ionization retentate chromatography mass spectrometry (SELDI-RC-MS): a new method for rapid development of process chromatography conditions
    S R Weinberger
    Ciphergen Biosystems, Inc, 6611 Dumbarton Circle, Fremont, CA 94555, USA
    J Chromatogr B Analyt Technol Biomed Life Sci 782:307-16. 2002
  4. ncbi Tagless extraction-retentate chromatography: a new global protein digestion strategy for monitoring differential protein expression
    Scot R Weinberger
    Ciphergen Biosystems, Inc, Fremont, CA 94555, USA
    Electrophoresis 23:3182-92. 2002
  5. ncbi Protein biochips for differential profiling
    E T Fung
    Ciphergen Biosystems, 6611 Dumbarton Circle, Fremont, CA 94555, USA
    Curr Opin Biotechnol 12:65-9. 2001
  6. ncbi Limited acid hydrolysis as a means of fragmenting proteins isolated upon ProteinChip array surfaces
    S Lin
    Ciphergen Biosystems, Fremont, CA 94555, USA
    Proteomics 1:1172-84. 2001
  7. ncbi The use of SELDI ProteinChip array technology in renal disease research
    Eric Fung
    Ciphergen Biosystems Inc, Fremont, CA, USA
    Methods Mol Med 86:295-312. 2003
  8. ncbi Classification of cancer types by measuring variants of host response proteins using SELDI serum assays
    Eric T Fung
    Ciphergen Biosystems, Fremont, CA 94555, USA
    Int J Cancer 115:783-9. 2005
  9. ncbi Bioinformatics approaches in clinical proteomics
    Eric T Fung
    Ciphergen Biosystems, Inc, 6611 Dumbarton Circle, Fremont, CA 94555, USA
    Expert Rev Proteomics 2:847-62. 2005
  10. ncbi Current developments in SELDI affinity technology
    Ning Tang
    Ciphergen Biosystems, 6611 Dumbarton Circle, Fremont, California 94555, USA
    Mass Spectrom Rev 23:34-44. 2004

Collaborators

Detail Information

Publications10

  1. ncbi Recent trends in protein biochip technology
    S R Weinberger
    Ciphergen Biosystems, Inc, 6611 Dumbarton Circle, Fremont, CA 94555, USA
    Pharmacogenomics 1:395-416. 2000
    ....
  2. ncbi Current achievements using ProteinChip Array technology
    Scot R Weinberger
    Ciphergen Biosystems, 6611 Dumbarton Circle, Fremont, California 94555, USA
    Curr Opin Chem Biol 6:86-91. 2002
    ..In clinical research, it has been used to elucidate and identify biomarkers of disease, and as a platform for predictive medicine...
  3. ncbi Surface-enhanced laser desorption-ionization retentate chromatography mass spectrometry (SELDI-RC-MS): a new method for rapid development of process chromatography conditions
    S R Weinberger
    Ciphergen Biosystems, Inc, 6611 Dumbarton Circle, Fremont, CA 94555, USA
    J Chromatogr B Analyt Technol Biomed Life Sci 782:307-16. 2002
    ..Analysis of collected LC fractions showed favorable correlation to results predicted by the RC-MS method...
  4. ncbi Tagless extraction-retentate chromatography: a new global protein digestion strategy for monitoring differential protein expression
    Scot R Weinberger
    Ciphergen Biosystems, Inc, Fremont, CA 94555, USA
    Electrophoresis 23:3182-92. 2002
    ..It is envisioned that tagless extraction-RCMS will evolve to be a valuable approach for both basic research and clinical proteomics endeavors...
  5. ncbi Protein biochips for differential profiling
    E T Fung
    Ciphergen Biosystems, 6611 Dumbarton Circle, Fremont, CA 94555, USA
    Curr Opin Biotechnol 12:65-9. 2001
    ..The past year has also seen the development of several novel chip types designed to analyze proteins in a fashion analogous to the array-based format of DNA microarrays. Some of these platforms may be used for differential profiling...
  6. ncbi Limited acid hydrolysis as a means of fragmenting proteins isolated upon ProteinChip array surfaces
    S Lin
    Ciphergen Biosystems, Fremont, CA 94555, USA
    Proteomics 1:1172-84. 2001
    ..Based upon the preliminary results of this work, we continue to explore the possibility of using limited acid hydrolysis to identify unknown proteins captured on ProteinChip array surfaces...
  7. ncbi The use of SELDI ProteinChip array technology in renal disease research
    Eric Fung
    Ciphergen Biosystems Inc, Fremont, CA, USA
    Methods Mol Med 86:295-312. 2003
  8. ncbi Classification of cancer types by measuring variants of host response proteins using SELDI serum assays
    Eric T Fung
    Ciphergen Biosystems, Fremont, CA 94555, USA
    Int J Cancer 115:783-9. 2005
    ....
  9. ncbi Bioinformatics approaches in clinical proteomics
    Eric T Fung
    Ciphergen Biosystems, Inc, 6611 Dumbarton Circle, Fremont, CA 94555, USA
    Expert Rev Proteomics 2:847-62. 2005
    ..Emphasis is placed on the process of mining high-dimensional data to identify a specific set of biomarkers that may be used in a diagnostic or other assay setting...
  10. ncbi Current developments in SELDI affinity technology
    Ning Tang
    Ciphergen Biosystems, 6611 Dumbarton Circle, Fremont, California 94555, USA
    Mass Spectrom Rev 23:34-44. 2004
    ..Finally, a detailed review of the specific use of such affinity surfaces in fundamental aspects of clinical, process, and research proteomics activity is presented...